Apatinib inhibits tumour progression and promotes antitumour efficacy of cytotoxic drugs in oesophageal squamous cell carcinoma

Apatinib, a highly selective inhibitor of vascular endothelial growth factor receptor‐2 (VEGFR‐2), inhibits the angiogenesis of tumours. The function and mechanism of apatinib in oesophageal squamous cell carcinoma (ESCC) remain unknown. In present study, we found that the development of ESCC in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Yanyan, Wang, Feng, Zhang, Yana, Shan, Zhengzheng, Tao, Weili, Lian, Yujin, Xin, Dao, Fan, Qingxia, Sun, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980885/
https://www.ncbi.nlm.nih.gov/pubmed/35315581
http://dx.doi.org/10.1111/jcmm.17209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980885/
https://www.ncbi.nlm.nih.gov/pubmed/35315581
http://dx.doi.org/10.1111/jcmm.17209

Ejemplares similares